Recent News

• 09.29.2025 - uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
• 09.26.2025 - uniQure Announces Pricing of Upsized $300 Million Public Offering
• 09.24.2025 - uniQure Announces $200 Million Proposed Public Offering
• 09.24.2025 - uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
• 09.24.2025 - uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
• 09.05.2025 - uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Recent Filings

• 09.29.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 09.29.2025 - EX-99.1 EX-99.1
• 09.29.2025 - 8-K Current report
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 144 Report of proposed sale of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.24.2025 - 8-K Current report
• 09.24.2025 - EX-99.1 EX-99.1
• 09.24.2025 - 144 Report of proposed sale of securities
• 09.24.2025 - 424B5 Prospectus [Rule 424(b)(5)]